China Pharma Inc. (CPHI)
AMEX: CPHI
· Real-Time Price · USD
1.45
-0.01 (-0.68%)
At close: Aug 15, 2025, 12:38 PM
China Pharma Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.00 | -8.31 | -9.13 | -6.95 | -12.81 | -13.04 | -25.15 | -71.48 | -19.76 | -57.31 | -94.79 | -52.61 | -85.78 | -94 | -389.63 | -505.61 | -631.23 |
PEG Ratio | -0.00 | -0.99 | 0.33 | -0.31 | 0.33 | -0.21 | -1.1 | 0.94 | -1.04 | 0.78 | -1.73 | 5.00 | 7.84 | -0.37 | n/a | -85.95 | 16.07 |
PS Ratio | 0.00 | 35.88 | 37.13 | 43.23 | 35.76 | 29.90 | 43.38 | 154.45 | 80.36 | 105.78 | 152.52 | 322.53 | 575.86 | 399.01 | 651.15 | 690.54 | 821.51 |
PB Ratio | 12.31 | 5.25 | 6.26 | 5.40 | 5.91 | 8.62 | 12.80 | 38.96 | 33.74 | 72.03 | 105.77 | 129.27 | 172.97 | 191.58 | 187.95 | 255.65 | 270.37 |
P/FCF Ratio | -618.13 | -1.18K | -1.08K | -396.66 | -83.72 | -2.39K | 78.22 | -783.46 | -107.3 | 710.02 | -8.97K | -1.02K | -1.05K | -5.62K | -1.49K | 2.52K | -7K |
P/OCF Ratio | -1.48K | 170.63 | -869.91 | -549.85 | -83.72 | -2.88K | 77.67 | -783.46 | -107.3 | 528.55 | 1.37K | -1.56K | -1.05K | -5.82K | -2.86K | 2.47K | -7K |
OCF/S Ratio | -0.00 | 0.21 | -0.04 | -0.08 | -0.43 | -0.01 | 0.56 | -0.2 | -0.75 | 0.20 | 0.11 | -0.21 | -0.55 | -0.07 | -0.23 | 0.28 | -0.12 |
Debt / Equity Ratio | 0.50 | 0.46 | 0.61 | 0.55 | 0.50 | 0.62 | 0.88 | 1.79 | 1.85 | 2.04 | 3.57 | 2.63 | 2.23 | 2.08 | 1.10 | 1.23 | 1.01 |
Quick Ratio | 0.17 | 0.20 | 0.26 | 0.24 | 0.25 | 0.33 | 0.29 | 0.15 | 0.19 | 0.24 | 0.22 | 0.33 | 0.43 | 0.55 | 0.10 | 0.19 | 0.11 |
Current Ratio | 0.56 | 0.65 | 0.79 | 0.84 | 0.89 | 0.88 | 0.82 | 0.52 | 0.51 | 0.47 | 0.44 | 0.75 | 0.82 | 0.86 | 0.40 | 0.43 | 0.44 |
Asset Turnover | 79.92K | 0.08 | 0.08 | 0.06 | 0.08 | 0.13 | 0.12 | 0.07 | 0.11 | 0.16 | 0.12 | 0.09 | 0.08 | 0.13 | 0.11 | 0.12 | 0.12 |
Interest Coverage | 27.07 | -40.23 | -31.81 | -28.91 | -21.73 | -23.57 | -10.77 | -3.31 | 12.00 | -12.26 | -6.62 | -7.08 | -7.33 | 2.32 | -11.75 | -10.4 | -9.77 |
Return on Equity | -112.71K | -0.16 | -0.17 | -0.19 | -0.12 | -0.17 | -0.13 | -0.14 | -0.43 | -0.31 | -0.28 | -0.61 | -0.5 | -0.51 | -0.12 | -0.13 | -0.11 |
Return on Assets | -55.26K | -0.08 | -0.08 | -0.1 | -0.06 | -0.07 | -0.05 | -0.04 | -0.11 | -0.08 | -0.05 | -0.14 | -0.13 | -0.14 | -0.05 | -0.04 | -0.04 |
Return on Invested Capital | -67.68K | -0.1 | -0.1 | -0.11 | -0.07 | -0.09 | -0.06 | -0.04 | 0.28 | -0.09 | -0.05 | -0.14 | -0.13 | 0.12 | -0.05 | -0.05 | -0.05 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -0.12 | -0.14 | -0.47 | -1.21 | -0.21 | -0.07 | -0.13 | -0.13 | 0.09 | 0.01 | -0.07 | -0.14 | -0.11 | 0.10 | -0.15 | 0.03 | 0.12 |
Net Profit Margin | -0.69 | -1.08 | -1.02 | -1.55 | -0.7 | -0.57 | -0.43 | -0.54 | -1.02 | -0.46 | -0.4 | -1.53 | -1.68 | -1.06 | -0.42 | -0.34 | -0.33 |
Pretax Profit Margin | -0.69 | -1.08 | -1.02 | -1.55 | -0.7 | -0.57 | -0.43 | -0.54 | -0.24 | -0.43 | -0.4 | -0.55 | -0.64 | -0.34 | -0.42 | -0.34 | -0.33 |
Operating Profit Margin | -0.67 | -1.05 | -0.99 | -1.5 | -0.67 | -0.55 | -0.4 | -0.42 | 0.49 | -0.4 | -0.35 | -0.48 | -0.57 | 0.27 | -0.39 | -0.31 | -0.3 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -0.67 | -0.66 | -0.35 | -0.7 | -0.13 | -0.23 | -0.02 | 0.22 | 0.14 | -0.18 | -0.01 | -0.06 | -0.12 | 0.02 | 0.11 | -0.02 | 0.00 |